Evidence map›Paper›PMID 41714741›Full record

ArticleNature2026

Host control of persistent Epstein-Barr virus infection.

Axel Schmidt, T Madhusankha Alawathurage, Friederike S David, Yosuke Ogawa, Leonard Frach, Sylvia Richter, Merle Schaefer, Carina M Mathey, Sabrina K Henne, Japan COVID-19 Task Force and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Axel SchmidtInstitute of Human Genetics, School of Medicine, University of Bonn and University Hospital Bonn, Bonn, Germany. axel.schmidt@ukbonn.de.ORCID http://orcid.org/0000-0002-9780-7243
T Madhusankha AlawathurageInstitute of Human Genetics, School of Medicine, University of Bonn and University Hospital Bonn, Bonn, Germany.
Friederike S DavidInstitute of Human Genetics, School of Medicine, University of Bonn and University Hospital Bonn, Bonn, Germany.ORCID http://orcid.org/0000-0001-9521-5669
Yosuke OgawaDepartment of Genome Informatics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-5049-5764
Leonard FrachInstitute of Human Genetics, School of Medicine, University of Bonn and University Hospital Bonn, Bonn, Germany.ORCID http://orcid.org/0000-0001-6349-8772
Sylvia RichterInstitute of Human Genetics, School of Medicine, University of Bonn and University Hospital Bonn, Bonn, Germany.
Merle SchaeferInstitute of Human Genetics, School of Medicine, University of Bonn and University Hospital Bonn, Bonn, Germany.
Carina M MatheyInstitute of Human Genetics, School of Medicine, University of Bonn and University Hospital Bonn, Bonn, Germany.
Sabrina K HenneInstitute of Human Genetics, School of Medicine, University of Bonn and University Hospital Bonn, Bonn, Germany.
Japan COVID-19 Task Force
Andreas J ForstnerInstitute of Human Genetics, School of Medicine, University of Bonn and University Hospital Bonn, Bonn, Germany.
Alexander T DiltheyInstitute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.ORCID http://orcid.org/0000-0002-6394-4581
Anne-Katrin PröbstelCenter of Neurology, Department of Neuroimmunology, University Hospital and University Bonn, Bonn, Germany.ORCID http://orcid.org/0000-0002-7748-1872
Kaan BoztugClinic for Pediatric Immunology and Rheumatology, Center for Pediatrics and Adolescent Medicine, University Hospital Bonn, Bonn, Germany.
Markus M NöthenInstitute of Human Genetics, School of Medicine, University of Bonn and University Hospital Bonn, Bonn, Germany.ORCID http://orcid.org/0000-0002-8770-2464
Ho NamkoongDepartment of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
Yukinori OkadaDepartment of Genome Informatics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-0311-8472
Eva C BeinsInstitute of Human Genetics, School of Medicine, University of Bonn and University Hospital Bonn, Bonn, Germany.
Kerstin U LudwigInstitute of Human Genetics, School of Medicine, University of Bonn and University Hospital Bonn, Bonn, Germany. kerstin.ludwig@uni-bonn.de.ORCID http://orcid.org/0000-0002-8541-2519

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epstein-Barr virus (EBV) infects approximately 90-95% of the global population

Indexed as

Epstein-Barr Virus InfectionsHerpesvirus 4, HumanHost-Pathogen InteractionsAllelesB-LymphocytesEpistasis, GeneticFemaleGenome, ViralGenome-Wide Association StudyHIV InfectionsHLA AntigensHumansMaleMultifactorial InheritanceViral LoadHLA Antigens

Identifiers

PMID41714741
PMCPMC13171444

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.